InterVenn Biosciences Closes $201M Series C Round
The company said it planned to use the funds for the development of a liquid biopsy assay for predicting patient response to immune checkpoint inhibitors.
GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases
The GenomeWeb Index outperformed the Dow Jones, Nasdaq, and Nasdaq Biotechnology Index last month.
Pacific Biosciences Acquires Sample Preparation Firm Circulomics
PacBio said that Circulomics' customers would continue to receive products and support following the acquisition, PacBio's second over the last month.
Abcam to Acquire Life Science Research Tool Firm BioVision for $340M
BioVision, which has been supplying products to Abcam since 2003, generated $33.8 million in revenues last year.
The European Union has backed the project, called Droplet-Small-Seq, with a €146,000 Horizon 2020 research grant.